We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.37B
AUM Growth
+$20.7M
Cap. Flow
-$45.3M
Cap. Flow %
-1.04%
Top 10 Hldgs %
34.75%
Holding
670
New
29
Increased
74
Reduced
175
Closed
54

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$42.1M
2
NXPI icon
NXP Semiconductors
NXPI
+$26.3M
3
CVS icon
CVS Health
CVS
+$11M
4
GILD icon
Gilead Sciences
GILD
+$6.96M
5
CTSH icon
Cognizant
CTSH
+$6.85M

Top Sells

Rank Stock Value
1
ARMH
ARM HOLDINGS PLC ADS
ARMH
+$86.6M
2
DHR icon
Danaher
DHR
+$37.2M
3
FDS icon
Factset
FDS
+$20.1M
4
FISV
Fiserv Inc
FISV
+$4.93M
5
CHD icon
Church & Dwight Co
CHD
+$3.13M

Sector Composition

Rank Sector Weight
1 Technology 21.62%
2 Healthcare 18.51%
3 Consumer Staples 13.66%
4 Consumer Discretionary 9.87%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWN icon
426
Northwest Natural Holdings
NWN
$2.12B
$38K ﹤0.01%
625
-10
-2% -$626
LIND icon
427
Lindblad Expeditions
LIND
$2.24B
$36K ﹤0.01%
3,950
ABB
428
DELISTED
ABB Ltd
ABB
$36K ﹤0.01%
1,600
BWA icon
429
BorgWarner
BWA
$14B
$35K ﹤0.01%
1,136
FWONA icon
430
Liberty Media Series A
FWONA
$23.7B
$35K ﹤0.01%
1,279
-41
-3% -$899
LBTYA icon
431
Liberty Global Class A
LBTYA
$3.55B
$35K ﹤0.01%
1,031
-141
-12% -$4.48K
MSEX icon
432
Middlesex Water
MSEX
$1.1B
$35K ﹤0.01%
1,000
NEM icon
433
Newmont
NEM
$124B
$35K ﹤0.01%
900
XYL icon
434
Xylem
XYL
$28.5B
$35K ﹤0.01%
661
SHPG
435
DELISTED
Shire pic
SHPG
$35K ﹤0.01%
181
-30
-14% -$5.85K
LH icon
436
Labcorp
LH
$26.2B
$34K ﹤0.01%
291
MUR icon
437
Murphy Oil
MUR
$5.06B
$34K ﹤0.01%
1,125
TM icon
438
Toyota
TM
$223B
$34K ﹤0.01%
290
AZN icon
439
AstraZeneca
AZN
$246B
$33K ﹤0.01%
499
TROW icon
440
T. Rowe Price
TROW
$23.8B
$33K ﹤0.01%
500
IMN
441
DELISTED
Imation
IMN
$32K ﹤0.01%
50,000
AME icon
442
Ametek
AME
$59.3B
$31K ﹤0.01%
655
GD icon
443
General Dynamics
GD
$107B
$31K ﹤0.01%
200
TNDM icon
444
Tandem Diabetes Care
TNDM
$1.63B
$31K ﹤0.01%
+400
New +$29.2K
EPZM
445
DELISTED
Epizyme, Inc
EPZM
$30K ﹤0.01%
3,000
HII icon
446
Huntington Ingalls Industries
HII
$12.9B
$29K ﹤0.01%
188
PDI icon
447
PIMCO Dynamic Income Fund
PDI
$7.42B
$28K ﹤0.01%
+1,000
New +$28.4K
PPL
448
PPL Corp
PPL
$26.7B
$28K ﹤0.01%
824
TRV icon
449
Travelers Companies
TRV
$77.2B
$28K ﹤0.01%
241
WOLF icon
450
Wolfspeed
WOLF
$1.65B
$28K ﹤0.01%
1,095
-56,060
-98% -$1.45M

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Loring Wolcott & Coolidge Fiduciary Advisors held 670 positions worth $4.37B, up 0.48% from $4.35B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2016 filing shows 29 new, 74 increased, 175 reduced and 54 closed positions. Its largest new stake was Fortive: 1,311,673 shares worth $42.1M. The largest sale was ARM HOLDINGS PLC ADS, an estimated $86.6M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q3 2016 buy was Fortive: 1,311,673 shares worth $42.1M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to NXP Semiconductors in Q3 2016, an estimated $26.3M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q3 2016 reduction was Danaher, cutting an estimated $37.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited ARM HOLDINGS PLC ADS in Q3 2016, selling an estimated $86.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 35% of its $4.37B portfolio in Q3 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 29 new positions and closed 54 in Q3 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 0.48% quarter-over-quarter to $4.37B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2016, filed 1 Nov 2016.